Tarsadia Investments

Tarsadia Investments is a private investment firm based in Newport Beach, California, with an additional office in New York. The firm specializes in providing capital and strategic support to companies across various sectors, including healthcare, financial services, real estate, life sciences, and clean technology. Tarsadia Investments focuses on identifying and fostering businesses with substantial growth potential, offering flexible support that spans from the initial idea generation stage to public ownership. Through its multi-strategy approach, the firm seeks to make impactful investments globally, contributing to the development and success of diverse enterprises.

David Browne

CFO

Mitchell Caplan

President

Mitch Caplan

President

Greg Casserly

CEO

Tushar Patel

Chairman and Founder

Gautam Patel

Managing Director

Darshan Patel

Associate

Rishi N. Reddy

Managing Director - Head of Venture and Growth

Rishi N. Reddy

Managing Director and Head of Venture and Growth

Jay Santoro

Vice President

37 past transactions

Pagos

Series A in 2023
Pagos is a company that specializes in developing a software-as-a-service (SaaS) financial platform aimed at optimizing payment processing for businesses. Founded in 2021 and based in Wilmington, Delaware, Pagos offers a data platform and API-driven micro-services that can integrate seamlessly with various payment systems. Its solutions focus on normalizing, visualizing, aggregating, and monitoring payment data, which helps companies enhance performance, increase sales, and reduce the overall costs associated with payment acceptance. Additionally, Pagos provides tools that enable merchant companies to effectively manage their payments, fostering business growth and building long-term customer relationships.

Envisics

Series C in 2023
Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, focused on designing and developing advanced holographic projection systems and computational algorithms for head-up displays and head-mounted display applications. Established in 2009, Envisics specializes in light manipulation through phase-only holography, offering high-quality image projection that enhances the in-car experience. By leveraging holography and laser-based light sources, the company aims to transform automotive displays and improve safety for drivers. Through collaborations with leading automakers and tier-one suppliers, Envisics is working to bring innovative holographic technology to the automotive sector, enabling drivers to access critical information without distraction by seamlessly overlaying data onto their field of vision.

Matterworks

Convertible Note in 2023
Matterworks is a developer of an artificial intelligence platform focused on advancing the field of metabolomics within the life sciences. The company's technology enhances analytical capabilities, allowing scientific researchers to conduct faster and more comprehensive metabolomic screenings. By facilitating the discovery and engineering processes, Matterworks aims to accelerate scientific progress and support innovation in various biological applications.

Fathom

Series B in 2022
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Jüsto

Series B in 2022
Jüsto is an online grocery store chain that specializes in delivery-only services. It provides a broad selection of items including fruits, vegetables, meat products, beauty products, and household supplies directly to consumers' doorsteps. The company focuses on offering fresh and healthy food products at competitive prices through its user-friendly platform.

Kirilys Therapeutics

Seed Round in 2022
Kirilys is a biopharmaceutical company focused on developing precision oncology assets aimed at improving the quality of life for cancer patients. Currently in the preclinical stages, the firm is working on a drug that has shown promising potency, selectivity, and anti-tumor efficacy. This drug is designed to be administered orally, which may enhance its usability for clinicians. In addition to addressing various cancers, Kirilys is also dedicated to improving treatment options for patients with chronic kidney disease. Through its innovative approach, the company aims to contribute significantly to the field of oncology and patient care.

Chronus Health

Series A in 2022
Chronus Health, Inc. is a company that specializes in developing a portable diagnostic platform aimed at delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and based in Mountain View, California, the company's innovative system utilizes microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time test results. This capability allows for immediate diagnosis at the point of care, enhancing the efficiency of treatment and significantly improving patient outcomes. By enabling doctors to obtain lab results in minutes, Chronus Health facilitates timely decision-making in clinical settings.

Petal

Series D in 2022
Petal Card, Inc. is a credit card company focused on providing financial access to individuals without traditional credit histories, such as students and immigrants. Founded in 2015 and based in New York, the company utilizes machine learning to analyze users' digital financial records, allowing for cash flow underwriting as an alternative to conventional credit scoring. This innovative approach enables Petal to offer higher credit limits and lower rates compared to competing credit cards. The company's flagship product, the Petal Visa, is designed to promote responsible spending and credit-building, accompanied by a user-friendly digital application for managing payments. Petal aims to make credit more honest, simple, and accessible, fostering a financial environment that encourages users to succeed.

AvantStay

Series B in 2021
AvantStay, Inc. is a hospitality company founded in 2016 and based in Los Angeles, California, specializing in vacation rental homes. The company operates a next-generation platform that redefines travel and investment experiences by offering a highly curated selection of short-term rental properties tailored to guests' needs. With a portfolio exceeding 450 premier properties across more than 60 cities, AvantStay utilizes proprietary technology to facilitate seamless bookings and efficient property management. The company has established partnerships with various online travel agencies, enabling direct bookings and enhancing accessibility for travelers. AvantStay aims to provide an elevated and authentic experience for its customers while maintaining an asset under management exceeding $800 million.

Konfio

Series E in 2021
Konfio is a financial services platform based in Mexico City, founded in 2013, that caters to small and medium-sized enterprises (SMEs) and micro entrepreneurs. The company offers a range of financial solutions including corporate credit cards, working capital loans, online payment solutions, and life insurance products. Konfio's mission is to support the growth and productivity of SMEs in Mexico by providing convenient and affordable access to credit options. The platform uses proprietary algorithms that combine data and technology to assess creditworthiness, thereby serving customers who are often underserved by traditional banking institutions.

bolttech

Series A in 2021
Bolttech is an international InsurTech company specializing in AI-driven point-of-sale insurance solutions. Its platform offers a wide range of insurance products including device protection, travel, motor, property, life, and digital insurance to consumers worldwide, with a significant presence in Asia. Bolttech's technology enables seamless connections between insurers, distributors, and customers, facilitating efficient buying and selling of insurance products.

Konfio

Series E in 2021
Konfio is a financial services platform based in Mexico City, founded in 2013, that caters to small and medium-sized enterprises (SMEs) and micro entrepreneurs. The company offers a range of financial solutions including corporate credit cards, working capital loans, online payment solutions, and life insurance products. Konfio's mission is to support the growth and productivity of SMEs in Mexico by providing convenient and affordable access to credit options. The platform uses proprietary algorithms that combine data and technology to assess creditworthiness, thereby serving customers who are often underserved by traditional banking institutions.

Nubank

Series G in 2021
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil

Series D in 2021
Phil, Inc. is a healthcare technology company that specializes in prescription management services aimed at improving patient access to medications. Founded in 2015 and headquartered in San Francisco, the company operates a specialty Rx distribution platform that facilitates the seamless management of medications by automatically refilling prescriptions based on established cadences. Acting as a liaison among patients, prescribers, manufacturers, and pharmacists, Phil enhances the medication access process while offering complimentary home delivery services. The platform aims to remove barriers to medication access, ensuring that patients can start and adhere to their therapies effectively. By providing end-to-end visibility into the prescription life cycle, Phil maximizes reimbursement opportunities for pharmaceutical brands and enhances patient outcomes in the management of specialty drugs.

Yieldstreet

Series C in 2021
Yieldstreet is a management platform that provides retail investors access to income-generating investment products. Founded in 2015, It gives individuals access to alternative investments that have traditionally been off-limits to the average investor. With over $2.5 billion invested across multiple asset classes, Yieldstreet is changing the way people generate passive income by lowering and removing the barriers that historically kept these lucrative opportunities far out of reach. In 2013, founders Milind Mehere and Michael Weisz were frustrated that many investment strategies were typically reserved only for institutions and the ultra-wealthy. Typically, the average investor was left to choose between the stock market and bonds with falling yields - with few options in between. Asset-based investments had longer hold periods and a higher barrier of entry, keeping them well out of reach of accredited investors — even more so for unaccredited investors. As a result, they decided to leverage the growing fintech disruption to give more people access to these previously restricted alternative investments. Milind’s background in building companies combined with Michael’s decade-plus experience in investing and fund management formed the core of Yieldstreet. Passion for their investors and employees as well as a willing embrace of innovation, has been part of Yieldstreet’s identity from the beginning. Each decision to leverage a new technology, or investment strategy, or originate a new deal is made to put investors first. That drive has propelled Yieldstreet across all 50 states, crossing $100M invested in less than eight quarters, with the $1B milestone coming only three years later. In 2019, Yieldstreet’s membership had grown to 100,000, and a savings account for members was launched. Yieldstreet, since its launch in 2015, has not deviated from its goal to change investing for the better, nor has it slowed down. Yieldstreet was ranked number 46 on the Inc. 5000 list of the fastest-growing companies and has been recognized by Built In as one of the Best Places to Work. Yieldstreet today delivers wealth generation options and alternative investments for more than 330,000 investors and has returned more than $1.3 billion in principal/interest. Many alternative investment platforms only focus on one asset class, such as real estate or art. Yieldstreet’s offerings, accessed through cash or a low-fee IRA, cover a wide range of asset classes — art, real estate, legal, corporates, consumer, and commercial, via single investments or funds. Yieldstreet also offers its members short-term notes on offerings with a hold period between 3 and 6 months, which generally boast higher interest rates than money markets and CDs. Yieldstreet is headquartered in New York and has offices in Brazil, Greece, and Malta. Michael Weisz serves as President and Milind Mehere serves as CEO. Together, they manage a team of more than 140 employees, all working toward Yieldstreet’s one goal: to change the way people invest for the better.

Phil

Series C in 2021
Phil, Inc. is a healthcare technology company that specializes in prescription management services aimed at improving patient access to medications. Founded in 2015 and headquartered in San Francisco, the company operates a specialty Rx distribution platform that facilitates the seamless management of medications by automatically refilling prescriptions based on established cadences. Acting as a liaison among patients, prescribers, manufacturers, and pharmacists, Phil enhances the medication access process while offering complimentary home delivery services. The platform aims to remove barriers to medication access, ensuring that patients can start and adhere to their therapies effectively. By providing end-to-end visibility into the prescription life cycle, Phil maximizes reimbursement opportunities for pharmaceutical brands and enhances patient outcomes in the management of specialty drugs.

BYJU'S

Series F in 2021
BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing adaptive and engaging learning solutions to over 150 million students worldwide. The company aims to make high-quality education accessible to learners of all ages through its flagship product, BYJU's: The Learning App, and a diverse portfolio that includes brands such as Disney-BYJU's Early Learn, BYJU's FutureSchool, and WhiteHat Jr. BYJU'S employs personalized learning methodologies that cater to individual learning styles and paces, supported by a network of over 12,000 teachers. The platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a contextual and practical learning experience. Additionally, BYJU'S has formed innovative partnerships with major companies like Disney and Google to enhance engagement. Headquartered in India, BYJU'S operates in more than 21 countries and offers programs in over 8 languages, further solidifying its position as a leader in the education technology sector.

Loft

Series D in 2021
Loft is a residential real estate transactional marketplace based in São Paulo, Brazil, founded in 2018 by experienced entrepreneurs. As Brazil's first platform of its kind, Loft facilitates the buying and selling of properties for individuals, brokers, and publicly listed REITs managed by the company. The platform offers a searchable database that allows users to find, browse, and evaluate properties based on customer feedback and reviews. By utilizing proprietary transaction data and an end-to-end digital workflow, Loft modernizes the homebuying experience in Brazil, integrating various adjacent services to enhance the overall process for buyers and sellers.

Brightvine

Seed Round in 2021
Brightvine is a developer of a blockchain-powered platform that aims to enhance the efficiency and accessibility of the structured finance market. By combining decentralized finance (DeFi) with the global fixed-income market, Brightvine is digitizing traditional financial assets through a compliant infrastructure that allows for the tokenization of fixed-income products. This innovative approach not only facilitates faster and more cost-effective asset transactions but also opens up new investment opportunities for Web3 investors and creates additional sources of liquidity for institutional clients.

Igneo

Seed Round in 2021
Igneo specializes in e-waste recycling, focusing on converting low-grade electronic waste into sustainable metal concentrates. By utilizing patented multi-hearth technology, the company achieves a recovery rate of 98% for precious metals from e-waste, significantly surpassing traditional recycling methods. This innovative approach not only provides a cleaner and more efficient alternative to conventional mining and metal recycling but also addresses environmental concerns by reducing harmful emissions associated with precious metal recovery. Igneo's closed-loop model involves collaboration with original equipment manufacturers and smelters, further enhancing the sustainability of its operations. Through its services, Igneo aims to offer a responsible solution to the growing issue of electronic waste.

Creditas

Series E in 2020
Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

Cue

Series C in 2020
Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Nubank

Series F in 2019
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil

Series B in 2019
Phil, Inc. is a healthcare technology company that specializes in prescription management services aimed at improving patient access to medications. Founded in 2015 and headquartered in San Francisco, the company operates a specialty Rx distribution platform that facilitates the seamless management of medications by automatically refilling prescriptions based on established cadences. Acting as a liaison among patients, prescribers, manufacturers, and pharmacists, Phil enhances the medication access process while offering complimentary home delivery services. The platform aims to remove barriers to medication access, ensuring that patients can start and adhere to their therapies effectively. By providing end-to-end visibility into the prescription life cycle, Phil maximizes reimbursement opportunities for pharmaceutical brands and enhances patient outcomes in the management of specialty drugs.

Fathom

Venture Round in 2019
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Overseas Network

Seed Round in 2019
Overseas Network is a vast large network committed to giving insider info to travel experts for all traveller needs.

Metallica Commodities

Private Equity Round in 2019
Metallica Commodities engages in the trading of metals and minerals, focusing on both non-ferrous and ferrous materials. The company is notable for operating the world's first industrial facility dedicated to recycling printed circuit boards, highlighting its commitment to innovative recycling practices. In addition to its recycling efforts, Metallica Commodities is involved in mineral asset development, with projects located in countries such as Guyana, Uganda, Tanzania, and the Democratic Republic of the Congo. The company also processes aggregates and dimension stones, contributing to its diverse portfolio in the mining and materials sector.

TrueMotion

Venture Round in 2019
TrueMotion, Inc. is a Boston-based company that develops a smartphone-based telematics platform for insurance companies, aimed at enhancing driving safety. Founded in 2012 and previously known as Censio, the company utilizes advanced signal processing, machine learning, and data science to analyze smartphone sensor data. This technology allows insurers to differentiate between safe and risky drivers, rewarding safe driving behaviors with discounts on premiums. By promoting safer driving practices, TrueMotion contributes to reducing the number of driving accidents and fostering safer roads for all motorists.

Cue

Series B in 2018
Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Envisics

Seed Round in 2018
Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, focused on designing and developing advanced holographic projection systems and computational algorithms for head-up displays and head-mounted display applications. Established in 2009, Envisics specializes in light manipulation through phase-only holography, offering high-quality image projection that enhances the in-car experience. By leveraging holography and laser-based light sources, the company aims to transform automotive displays and improve safety for drivers. Through collaborations with leading automakers and tier-one suppliers, Envisics is working to bring innovative holographic technology to the automotive sector, enabling drivers to access critical information without distraction by seamlessly overlaying data onto their field of vision.

Nvoicepay

Series F in 2016
Nvoicepay, Inc. is a fintech company that specializes in cloud-based accounts payable software solutions designed to automate and optimize electronic invoice payments. Founded in 2009 and headquartered in Beaverton, Oregon, with an additional office in San Francisco, Nvoicepay enables customers to pay all of their invoices electronically. The platform helps businesses streamline their accounts payable processes by facilitating payments to suppliers through various electronic methods, thereby reducing costs and increasing operational efficiency. Nvoicepay also offers additional services such as payment command center, supplier enablement, and customer payment support. As of 2019, it operates as a subsidiary of FleetCor Technologies, Inc., and has formed strategic partnerships to enhance its service offerings.

Asana BioSciences

Seed Round in 2014
Asana BioSciences, LLC is a clinical-stage biopharmaceutical company based in Bridgewater, New Jersey, focused on the discovery and development of novel targeted therapies. Operating as a subsidiary of Amneal Pharmaceuticals, the firm specializes in research related to oncology, inflammation, immunology, and pain management. Asana BioSciences aims to advance multiple early-stage drug candidates through its development pipelines, enabling collaboration with partners to enhance the potential for successful commercialization of new treatment options. Through its innovative approach, the company seeks to provide effective therapies that can benefit both physicians and patients in addressing unmet medical needs.

DAQRI

Private Equity Round in 2013
DAQRI LLC is a company based in Los Angeles, California, specializing in augmented reality (AR) solutions aimed at enhancing workplace efficiency and safety. Founded in 2007, DAQRI develops a range of products, including its flagship 4D Studio, a web-based authoring tool designed for creating and managing immersive 4D experiences. The company also offers professional-grade AR wearables, such as smart glasses and helmets, which integrate digital content with the physical environment to streamline communication and productivity. Additionally, DAQRI provides industrial applications for sectors such as aerospace, healthcare, manufacturing, and education, focusing on training, maintenance, and real-time quality assurance. Its offerings include tools for visualizing data in augmented reality, as well as enterprise software and hardware integration services. With a presence in major U.S. cities and a commitment to driving innovation, DAQRI aims to empower workforces across various industries by improving operational processes and effectiveness.

Kashiv BioSciences

Seed Round in 2011
Kashiv BioSciences is a fully integrated biopharmaceutical company focused on the development and manufacturing of complex pharmaceuticals, including biosimilars and complex generics. With research and development facilities located in Piscataway, New Jersey; Chicago, Illinois; and Ahmedabad, India, the company boasts capabilities in mammalian and microbial cell line development, advanced analytical characterization, and commercial-scale manufacturing. Kashiv is committed to improving patient outcomes by creating enhanced versions of established medications and addressing unmet medical needs. Its product pipeline features biosimilar candidates such as KSHB002, an abatacept biosimilar that successfully met primary endpoints in a Phase I trial. Through its innovative approaches and technologies, Kashiv BioSciences aims to provide significant value to patients and healthcare providers.

Lereta

Private Equity Round in 2009
LERETA specializes in providing property tax data and flood hazard status information tailored for the mortgage and insurance industries across the United States. The company offers a technology-driven platform that facilitates regulatory-compliant property tax tracking, payment services, tax department outsourcing, and federally mandated flood zone certifications. By leveraging software-as-a-service (SaaS) technology, LERETA enables clients to enhance workflow management and automate various processes, ultimately improving efficiency and reducing potential penalties and liabilities. With a strong focus on customer service, LERETA's team of dedicated real estate tax and flood professionals, supported by experienced management, positions the company as a leader in service and technological innovation within its sector.

Prolong Pharmaceuticals

Seed Round in 2009
Prolong Pharmaceuticals, LLC is a biopharmaceutical company focused on developing products for hematology and oncology diseases. It is known for SANGUINATE, an investigational product designed to enhance oxygen delivery to cells and tissues, particularly addressing the complications associated with sickle cell disease and other conditions related to anemia or hypoxia. The company also works on ANF-Rho, which aims to create a novel molecule with a unique mechanism of action, and EPEG, a PEGylated erythropoietin biologic intended for treating anemia. Additionally, Prolong Pharmaceuticals is developing PP-403, a novel cytokine with potential applications in cancer treatment. Founded in 2002 and based in South Plainfield, New Jersey, the company engages in improving patient quality of life through innovative therapeutic solutions.

Amneal Pharmaceuticals

Post in 2005
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company that develops, licenses, manufactures, and markets a diverse range of generic and specialty pharmaceutical products. The company operates primarily through two segments: Generics and Specialty. The Generics segment focuses on creating complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across various therapeutic categories. The Specialty segment is dedicated to the development and sale of branded pharmaceutical products, particularly for central nervous system disorders, endocrinology, and parasitic infections. Notable products include Rytary for Parkinson's disease, Zomig for migraines, Emverm for parasitic infections, and Unithroid for hypothyroidism. Amneal Pharmaceuticals distributes its products through wholesalers, distributors, hospitals, and pharmacies, with operations in the United States, India, Ireland, and other international markets. Founded in 2002 and headquartered in Bridgewater, New Jersey, the company was previously known as Atlas Holdings, Inc. before rebranding in 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.